These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2334917)

  • 1. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods.
    Yang LY; Trujillo JM
    Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells.
    Yang LY; Trujillo JM; Su YZ
    Anticancer Res; 1992; 12(2):473-9. PubMed ID: 1349796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
    Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
    Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular P-glycoprotein in multidrug resistant tumor cells.
    Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
    Slovak ML; Hoeltge GA; Dalton WS; Trent JM
    Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
    Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.
    Ganapathi R; Grabowski D; Schmidt H; Bell D; Melia M
    Cancer Res; 1987 Jul; 47(13):3464-8. PubMed ID: 2884031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between multidrug resistance in human colon carcinoma LoVo/Adr cell line and intracellular calcium ion concentration].
    Ma Q; Zhang ZS; Zhang YL; Lai ZS
    Ai Zheng; 2002 Aug; 21(8):846-9. PubMed ID: 12478890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction.
    Yang KP; Liang YF; Samaan NA
    Anticancer Res; 1991; 11(3):1065-8. PubMed ID: 1888139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone.
    Dalton WS; Cress AE; Alberts DS; Trent JM
    Cancer Res; 1988 Apr; 48(7):1882-8. PubMed ID: 2894893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.
    Mazzoni A; Trave F; Fabbri M; Leto G; Ghidoni R
    Anticancer Res; 1991; 11(6):2181-5. PubMed ID: 1776860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphoglycoprotein associated with taxol resistance in J774.2 cells.
    Roy SN; Horwitz SB
    Cancer Res; 1985 Aug; 45(8):3856-63. PubMed ID: 2861892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.